Walgreens deploys large-scale EHR system

Laura Pedulli | | Health Exec | EMR/EHR

Walgreens has completed a rollout of its EHR solution, offering pharmacy staff at its 8,200 locations a single reference point for patient information.

The EHR allows pharmacists to identify opportunities to close gaps in care and share patient information with other healthcare organizations, according to the retailer.

“Having a chain-wide EHR platform enhances our pharmacists’ ability to provide individualized immunization and health testing recommendations, which is key to closing gaps in patient care that exist today,” said Tim Theriault, Walgreens senior vice president, chief information, innovation and improvement officer, in a statement.

The single EHR will link a total of 27,000 pharmacists. Walgreens estimates that it will process 20,000 patient encounters per hour.

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.